Synergia and Bolster have secured acquisition financing for Life & Mobility

August 2026 — Synergia Capital Partners and Bolster Investment Partners have partnered with Life & Mobility, a leading Dutch developer and manufacturer of premium mobility and rehabilitation solutions. The partnership marks an important next step in Life & Mobility’s growth trajectory, focused on further international expansion, continued product innovation and strengthening its leading market position.

Life & Mobility designs, develops and manufactures innovative mobility products that enhance end users’ independence and quality of life. Headquartered in Doetinchem, the Netherlands, the company has grown into one of Europe’s leading players in the premium mobility aids market. Its strong market position is built on in-house research and development (R&D) capabilities, a focus on product quality and user-centric innovation and a differentiated environmental, social and governance (ESG) proposition centered on refurbishment, product longevity and circular mobility solutions.

Our role in the transaction

Oaklins’ debt advisory team in the Netherlands acted as the exclusive debt advisor to Synergia and Bolster. The team arranged a tailored unitranche financing package, provided by Robeco, to support the acquisition and Life & Mobility’s future growth ambitions. The financing process included an extensive lender education phase, which generated significant interest from a broad group of banks and direct lenders and resulted in a highly competitive process. Working closely with Robeco, the sponsors and management, the team negotiated and executed the financing on attractive terms, providing long-term flexibility to support Life & Mobility’s continued growth. The financing process was executed alongside Oaklins’ role as the exclusive sell-side M&A advisor to Life & Mobility’s shareholders, demonstrating Oaklins’ ability to deliver fully integrated corporate finance solutions. The transaction further strengthens the team’s track record in sponsor-backed financing processes in the healthcare sector.